Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Published: August 2021The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: December 2013This guide reviews screening tools for alcohol use and interventions for pregnant women and women of childbearing age to prevent fetal alcohol spectrum disorders (FASD). It also outlines methods for identifying people living with FASD and modifying treatment accordingly. Access the literature review.
Published: September 2013This manual offers guidelines to help counselors and administrators deliver substance use disorder treatment in criminal justice settings. It discusses aspects in providing substance use disorder treatment to people within the criminal justice system, including screening and assessment, and triage and placement in treatment services.
Published: May 2013This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.
Published: July 2012This manual helps clinicians improve care for people living with HIV/AIDS and substance use disorder conditions. It discusses prevention, assessment, and treatment of HIV/AIDS. The manual also examines mental illness, integrated services, case management, counseling, ethical and legal issues, and funding sources.